Ultra Sensitive Support meets your Regulatory Requirements

From internal decision making to GLP/GCP regulated studies, we make sure to deliver immunoassay sensitivity under the regulatory regime you need

The development of biotherapeutic drugs is a very complex process which presents many challenges that may change over the curse of the study. With regard to bioanalytical support, requirements for sensitivity, sample volume availability, overall assay performance, and quantification range, in addition to the regulatory requirements which may change over the different phases of a compound’s pharmaceutical development, Chimera Biotec is specialized in overcoming these challenges. Relying on our cumulative expert knowledge and laboratory capabilities, we deliver top-quality bioanalysis on-time.

As a service provider, we have developed technical capabilities on several ultra sensitive platforms, starting with high sensitivity (HS) ELISA, Simoa technology from Quanterix, as well as our own Immuno-PCR (IPCR) platform technology, Imperacer®. We deliver immunoassays to fulfill even your most challenging study requirements.

At our GLP/GCP regulated bioanalytical laboratories, we handle your samples with the greatest care. We are organized to take part in complex multi-center trials. Upon receipt, samples are directly stowed in 24/7 monitored frozen storage.